Cargando…

The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow

BACKGROUND: Slow coronary flow (SCF) is an angiographic finding characterized with delayed opacification of epicardial coronary arteries without obstructive coronary disease. Urotensin II (UII) is an important vascular peptide, which has an important role in hypertension, coronary artery disease, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Şatıroğlu, Ömer, Durakoğlugil, Murtaza Emre, Çetin, Mustafa, Çiçek, Yüksel, Erdoğan, Turan, Duman, Hakan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Akadémiai Kiadó 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283774/ https://www.ncbi.nlm.nih.gov/pubmed/28180005 http://dx.doi.org/10.1556/1646.8.2016.4.1

Ejemplares similares

Prolonged QRS duration on surface electrocardiogram is associated with left ventricular restrictive filling pattern
por: Erdoğan, Turan, et al.
Publicado: (2017)

Absence and Resolution of Fragmented QRS Predict Reversible Myocardial Ischemia With Higher Probability of ST Segment Resolution in Patients With ST Segment Elevation Myocardial Infarction
por: Cetin, Mustafa, et al.
Publicado: (2012)

Hair whitening and obesity are independently related to ascending aorta dilatation in young-middle aged men
por: Cetin, Mustafa, et al.
Publicado: (2018)

The Independent Relationship of Systemic Inflammation With Fragmented QRS Complexes in Patients With Acute Coronary Syndromes
por: Çetin, Mustafa, et al.
Publicado: (2012)

Bilirubin Level is Associated with Left Ventricular Hypertrophy Independent of Blood Pressure in Previously Untreated Hypertensive Patients
por: Ayaz, Teslime, et al.
Publicado: (2014)

Relation of Angiographic Thrombus Burden with Severity of Coronary Artery Disease in Patients with ST Segment Elevation Myocardial Infarction
por: Duman, Hakan, et al.
Publicado: (2015)

The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study
por: Zengin, Halit, et al.
Publicado: (2015)

The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol
por: Durakoğlugil, Murtaza Emre, et al.
Publicado: (2015)

An increase in epicardial adipose tissue is strongly associated with carotid intima-media thickness and atherosclerotic plaque, but LDL only with the plaque
por: Kocaman, Sinan Altan, et al.
Publicado: (2017)

The relationship between total atrial conduction time and left atrial global strain in patients with psoriasis vulgaris
por: Duman, Hakan, et al.
Publicado: (2019)

Decreased left atrial strain parameters are associated with prolonged total atrial conduction time in lichen planus
por: Duman, Hakan, et al.
Publicado: (2018)

Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits
por: Yu, Qing-qing, et al.
Publicado: (2019)

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

Methemoglobinemia due to local anesthesia: a rare cause of cyanosis and chest pain after placement of implantable cardioverter defibrillator
por: Cicek, Yuksel, et al.
Publicado: (2020)

Epicardial adipose tissue thickness and plasma homocysteine in patients with metabolic syndrome and normal coronary arteries
por: Balcioğlu, Akif Serhat, et al.
Publicado: (2014)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells
por: Park, Sung Lyea, et al.
Publicado: (2013)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

Coronary Slow Flow Accompanying Exertional Blurred Vision and Effects of Corticosteroids
por: Koç, Şahbender, et al.
Publicado: (2015)

Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions
por: Ulas, Turgay, et al.
Publicado: (2013)

Coronary slow flow: Benign or ominous?
por: Anwar, Mohammed Omer, et al.
Publicado: (2016)

Relationship between platelet-to-lymphocyte ratio and coronary slow flow
por: Oylumlu, Muhammed, et al.
Publicado: (2015)

Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome?
por: Babińska, Magdalena, et al.
Publicado: (2012)

Author’s Reply
por: Durakoğlugil, Murtaza Emre
Publicado: (2015)

Evaluation of serum prolidase activity in patients with slow coronary flow
por: Suner, Arif, et al.
Publicado: (2015)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Urotensin II levels in patients with chronic kidney disease and kidney transplants
por: Hursitoglu, Mehmet, et al.
Publicado: (2012)

The effect of blood cell count on coronary flow in patients with coronary slow flow phenomenon
por: Soylu, Korhan, et al.
Publicado: (2014)

Plasma urotensin II and neurokinin B levels in acute myocardial infarction and stable coronary artery disease
por: Akkoyun, Dursun Çayan, et al.
Publicado: (2016)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

A closer look at the role of urotensin II in the metabolic syndrome
por: Barrette, Pierre-Olivier, et al.
Publicado: (2012)

Urotensin II in Invertebrates: From Structure to Function in Aplysia californica
por: Romanova, Elena V., et al.
Publicado: (2012)

Irisin levels are associated with urotensin II levels in diabetic patients
por: He, Wan-Yu, et al.
Publicado: (2015)

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
por: Portnoy, Alison, et al.
Publicado: (2013)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
por: Simunovic, Marko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h0odclknvil9odep5084kvh34b